Triple Intrathecal Combination Therapy for End-Stage Cancer-Related Refractory Pain: A Prospective Observational Study with Two-Month Follow-Up

ConclusionsOur results, within the limit of the study design, suggest that the IT combination of ziconotide, morphine, and levobupivacaine, at low doses, allows safe and rapid control of refractory cancer pain, with high levels of patient satisfaction.

http://link.springer.com/10.1007/s40122-020-00169-1

Source: Pain and Therapy - April 28, 2020 Category: Anesthesiology Source Type: research